Leukotriene E4 and endothelin-1 levels, their response to the therapy, potential relationship with gastroesophageal reflux and developing of infantile asthma in wheezy infants Hışıltılı çocuklarda lökotrien E4 ve endotelin-1 düzeyleri, tedaviye yanıt, gastroösefageal reflü ve süt çocuǧu astımı gelişmesi ile potansiyel i̇lişkileri


Kocak A. K. , Yildiz B., Dinleyici C. , Bulut I., Akgun Y., BAL C.

Turkiye Klinikleri Journal of Medical Sciences, cilt.30, sa.1, ss.157-163, 2010 (SCI Expanded İndekslerine Giren Dergi) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Konu: 1
  • Basım Tarihi: 2010
  • Doi Numarası: 10.5336/medsci.2008-8889
  • Dergi Adı: Turkiye Klinikleri Journal of Medical Sciences
  • Sayfa Sayıları: ss.157-163

Özet

Objective: Wheezing is a common symptom among children and is proposed to be associated with inflammatory cell infiltration, cytokines production, and with some risk factors such as gastro esophageal reflux (GER). The aim of the present study was to investigate endotheline-1 (ET-1) and leukotriene-E4 (LTE-4) levels, their response to steroid and β2-agonist therapy, and to establish if these parameters can be used as a diagnostic tool for infantile asthma and assess their relation with GER during acute attack of wheezy infants (WI). Material and Methods: Thirty WI and 12 healthy infants were enrolled in the present study. Serum IgE, ET-1, urine LTE- 4 levels, and eosinophil percentage were measured prior to and 5 days after the treatment (systemic or inhaled steroid therapy and inhaled β2-agonist) in children with WI. In addition, esophageal pH was monitored for 24 hours. Results: Serum IgE, ET-1, and urine LTE-4 levels were significantly higher in the patients compared to the controls before and five days after the treatment (p= 0.009; p= 0.039, p= 0.032; p= 0.014, p= 0.017, respectively). The serum IgE and urine LTE-4 levels prior to and 5 days after the treatment were higher in the patients with GER when compared to the controls (p= 0.021, p= 0.016 and p= 0.039). Moreover, the systemic or inhaled steroid therapy did not influence the serum ET-1 and urine LT-E4 levels. We found that the serum IgE and ET-1 levels on 5th day of the treatment and LTE-4 levels at the beginning and 5th day of the treatment were notably different in patients with higher likelihood for developing infantile asthma when compared to the controls. Finally, increased serum IgE levels were present in patients with good response to inhaled β2-agonist with regard to those with poor response to inhaled β2-agonist (p= 0.031). Conclusion: The present study indicated that IgE, ET-1 and LTE-4 levels were related to airway inflammation in WI while LTE-4 and IgE levels were associated with GER. LTE-4 and IgE levels could be novel parameters for determining the risk factor for developing asthma in child with WI. Inhaled β2-agonist therapy seemed to be beneficial only in patients with high serum IgE levels. © 2010 by Türkiye Klinikleri.